"CONCLUSIONS
Patients with hyperkalemia who received ZS-9, as compared with those who received placebo, had a significant reduction in potassium levels at 48 hours, with normokalemia maintained during 12 days of maintenance therapy. (Funded by ZS Pharma; ClinicalTrials.gov number, NCT01737697.)"
http://www.nejm.org/doi/full/10.1056/NEJMoa1411487?query=featured_home
No comments:
Post a Comment